XNAS
MLTX
Market cap889mUSD
Oct 08, Last price
10.58USD
1D
-1.76%
1Q
-48.04%
IPO
0.57%
Name
MoonLake Immunotherapeutics
Chart & performance
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
34.21%
Rev. gr., 5y
%
Revenues
0
Net income
-227m
L+91.13%
CFO
-196m
L+68.12%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in Boston, Massachusetts, in 2020, Helix Acquisition Corp. currently possesses no substantial business operations. Its sole purpose is to undertake a business combination, such as a merger, acquisition, or reorganization, involving one or more other entities.
Key people
Independent Chairman of the Board · since 2022
Matthias Bodenstedt
Chief Financial Officer · since 2022
Kristian Reich
Chief Scientific Officer · since 2022
Jorge Santos Da Silva
Chief Executive Officer, Director · since 2022
Spike Loy
Independent Director · since 2022
Independent Director · since 2022
Andrew Phillips
Independent Director · since 2022
Ramnik Xavier
Independent Director · since 2022
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||